Hepatosplenic T cell lymphoma medical therapy: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
No edit summary
Mmir (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, nocaptcha, smwadministrator, Administrators, Widget editors
14,850 edits
Mahshid
 
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{AS}}
==Overview==
==Overview==
The predominant therapy for hepatosplenic T cell lymphoma is [[chemotherapy]]. Adjunctive stem cell transplant ([[SCT]]) may be required.
The predominant therapy for hepatosplenic T cell lymphoma is [[chemotherapy]]. Adjunctive stem cell transplant may be required.


==Medical Therapy==
==Medical Therapy==
The predominant therapy for hepatosplenic T cell lymphoma is [[chemotherapy]]. Adjunctive stem cell transplant may be required.
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+ '''Treatment of hepatosplenic T cell lymphoma<ref name= canadiancancer>Hepatosplenic T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/hepatosplenic-t-cell-lymphoma/?region=nb. Accessed on February 23, 2016 </ref>'''
|+ '''Treatment of hepatosplenic T cell lymphoma<ref name= canadiancancer>Hepatosplenic T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/hepatosplenic-t-cell-lymphoma/?region=nb. Accessed on February 23, 2016 </ref>'''
Line 13: Line 15:
| style="padding: 5px 5px; background: #DCDCDC;" | Chemotherapy
| style="padding: 5px 5px; background: #DCDCDC;" | Chemotherapy
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
* Most often, people with hepatosplenic T cell lymphoma are treated with combination chemotherapy
* Most often, patients with hepatosplenic T cell lymphoma are treated with combination chemotherapy
* Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]]  {{and}} [[Vincristine]] {{and}} [[Prednisone]]  
* Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]]  {{and}} [[Vincristine]] {{and}} [[Prednisone]]  
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | Stem cell transplant  
| style="padding: 5px 5px; background: #DCDCDC;" | Stem cell transplant  
| style="padding: 5px 5px; background: #F5F5F5;" |   
| style="padding: 5px 5px; background: #F5F5F5;" |   
* A stem cell transplant ([[SCT]]) may be an option for some people with hepatosplenic T cell lymphoma
* A stem cell transplant may be an option for some patients with hepatosplenic T cell lymphoma
|}
|}


Line 31: Line 33:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]

Latest revision as of 02:01, 27 November 2017

Hepatosplenic T cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatosplenic T cell lymphoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatosplenic T cell lymphoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatosplenic T cell lymphoma medical therapy

CDC on Hepatosplenic T cell lymphoma medical therapy

Hepatosplenic T cell lymphoma medical therapy in the news

Blogs on Hepatosplenic T cell lymphoma medical therapy

Directions to Hospitals Treating Hepatosplenic T cell lymphoma

Risk calculators and risk factors for Hepatosplenic T cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

The predominant therapy for hepatosplenic T cell lymphoma is chemotherapy. Adjunctive stem cell transplant may be required.

Medical Therapy

The predominant therapy for hepatosplenic T cell lymphoma is chemotherapy. Adjunctive stem cell transplant may be required.

Treatment of hepatosplenic T cell lymphoma[1]
Therapy Description
Chemotherapy
Stem cell transplant
  • A stem cell transplant may be an option for some patients with hepatosplenic T cell lymphoma

References

  1. ↑ Hepatosplenic T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/hepatosplenic-t-cell-lymphoma/?region=nb. Accessed on February 23, 2016

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Hepatosplenic_T_cell_lymphoma_medical_therapy&oldid=1394340"